3 research outputs found
Liposomal Spherical Nucleic Acids
A novel
class of metal-free spherical nucleic acid nanostructures
was synthesized from readily available starting components. These
particles consist of 30 nm liposomal cores, composed of an FDA-approved
1,2-dioleoyl-<i>sn</i>-glycero-3-phosphocholine (DOPC)
lipid monomer. The surface of the liposomes was functionalized with
DNA strands modified with a tocopherol tail that intercalates
into the phospholipid layer of the liposomal core via hydrophobic
interactions. The spherical nucleic acid architecture not only stabilizes
these constructs but also facilitates cellular internalization and
gene regulation in SKOV-3 cells
Cross-Linked Micellar Spherical Nucleic Acids from Thermoresponsive Templates
A one-pot
synthesis of micellar spherical nucleic acid (SNA) nanostructures
using Pluronic F127 as a thermoresponsive template is reported. These
novel constructs are synthesized in a chemically straightforward process
that involves intercalation of the lipid tails of DNA amphiphiles
(CpG motifs for TLR-9 stimulation) into the hydrophobic regions of
Pluronic F127 micelles, followed by chemical cross-linking and subsequent
removal of non-cross-linked structures. The dense nucleic acid shell
of the resulting cross-linked micellar SNA enhances their stability
in physiological media and facilitates their rapid cellular internalization,
making them effective TLR-9 immunomodulatory agents. These constructs
underscore the potential of SNAs in regulating immune response and
address the relative lack of stability of noncovalent constructs
Drug-Loaded Polymeric Spherical Nucleic Acids: Enhancing Colloidal Stability and Cellular Uptake of Polymeric Nanoparticles through DNA Surface-Functionalization
Small-sized (∼65 nm) doxorubicin
(Dox)-loaded polymeric
nanoparticles (PNPs) were modified with oligonucleotides to form colloidally
stable Dox-loaded polymeric spherical nucleic acid (Dox-PSNA) nanostructures
in biological media. The nucleic acid shell facilitates the cellular
uptake of Dox-PSNA, which results in <i>in vitro</i> cytotoxicity
against SKOV3 cancer cells
